Evidence map›Paper›PMID 28483465›Full record

ArticleJournal of pediatric urology2017

Use of medical expulsive therapy in children: An assessment of nationwide practice patterns and outcomes.

Jonathan S Ellison, Paul A Merguerian, Benjamin C Fu, Sarah K Holt, Thomas S Lendvay, John L Gore, Margarett Shnorhavorian

Open access · greenAbstract readComparative Study
In one paragraph

Article in Journal of pediatric urology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Laser access and utilization preferences for pediatric ureteroscopy: A survey of the Societies of Pediatric Urology.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2022
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Jonathan S EllisonDivision of Pediatric Urology, Seattle Children's Hospital, Seattle, WA, USA. Electronic address: Jonathan.ellison@seattlechildrens.org.
Paul A MerguerianDivision of Pediatric Urology, Seattle Children's Hospital, Seattle, WA, USA.
Benjamin C FuDivision of Pediatric Urology, Seattle Children's Hospital, Seattle, WA, USA.
Sarah K HoltDepartment of Urology, University of Washington, Seattle, WA, USA.
Thomas S LendvayDivision of Pediatric Urology, Seattle Children's Hospital, Seattle, WA, USA.
John L GoreDepartment of Urology, University of Washington, Seattle, WA, USA.
Margarett ShnorhavorianDivision of Pediatric Urology, Seattle Children's Hospital, Seattle, WA, USA.
Seattle Children's Hospital · USUniversity of Washington · US

Funding

Contributing Factors and Consequences of Cancer Health DisparitiesT32CA094880 · NCI · UNIVERSITY OF WASHINGTON · PI Christopher I Li, AMANDA IRENE PHIPPS · 2017 to 2026
$3.7M
NCI NIH HHS T32 CA094880
6 · The paper itself

Abstract

introductionEarly data support the use of medical expulsive therapy (MET) in children. However, little is known regarding use or outcomes associated with MET outside of pediatric-specific practices. Using a national administrative dataset, we sought to characterize utilization patterns of MET as well as assess outcomes associated with MET exposure. STUDY

designWe interrogated the MarketScan Commercial Claims and Encounters database to identify children under the age of 18 presenting to the emergency department (ED) with any diagnosis of upper urinary tract calculi (UUTC, including renal and ureteral calculi). MET exposure was defined as having a prescription filled for a MET agent within 1 week of the ED encounter. Characteristics of children receiving MET were defined and outcomes compared between children with and without MET exposure.

resultsOf 1325 children included in the study, 13.2% received MET, including 15.4% of children with a diagnosis of "calculus of the ureter." MET use increased significantly throughout the study period (p = 0.004), although only 30.4% of children considered potential MET candidates received MET in the final year of the study (2013). Among all patients, receipt of MET was associated with male gender, presence of comorbidity, provider-type (urologist), and year of diagnosis, although among those with a specific diagnosis of "calculus of the ureter," only year of diagnosis remained a significant factor. Rates of unplanned physician visits and surgical interventions were similar between groups. Children receiving MET were more likely to receive follow-up imaging, although only 46% of children with ureteral calculi had appropriate follow-up imaging within 90 days, regardless of MET exposure. Odds ratios of factors and outcomes associated with MET exposure are shown in the Table. DISCUSSION: Although early data support safety and efficacy MET in children, nationwide use in children is low among potential candidates for MET. For children with ureteral calculi, only year of diagnosis was a significant factor associated with MET use. No difference in unplanned physician visits or surgical interventions was noted. Most notable, however, was the low rate of follow-up imaging within 90 days for children presenting acutely with UUTC.

conclusionsUse of MET for children with ureteral calculi is increasing, although still fewer than a third of children considered potential candidates receive this treatment. Follow-up imaging is not obtained for many children with ureteral calculi. Future work is needed to standardize management and follow-up protocols for children with acute renal colic.

Indexed as

Emergency Service, HospitalAdolescentAge FactorsAnalysis of VarianceChildChild, PreschoolCohort StudiesConfidence IntervalsDatabases, FactualFemaleFollow-Up StudiesHumansKidney CalculiMaleOdds RatioPregnancySulfonamidesTamsulosinUrological AgentsKidney calculiPediatricsTamsulosinUreteral calculi

Identifiers

PMID28483465
PMCPMC5947996
OpenAlexW2606779678

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.